Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020222666 - USE OF A CHIRAL 2-AZABICYCLOALKANE DERIVATIVE WITH DANSYL SUBSTITUENT AS VP24 PROTEASE INHIBITOR TO INHIBIT THE REPLICATION OF HSV-1 VIRUS

Note: Text based on automatic Optical Character Recognition processes. Please use the PDF version for legal matters

[ EN ]

AMENDED CLAIMS

received by the International Bureau on 28 September 2020 (28.09.2020)

Patent claim

Use of 5-(dimethylamino)-N-((l S,4S,5R)-2-((S)-l-phenylethyl)-2-azabicyclo[3.2.1]octan-4-yl)naphthalene-l-sulfonamide (formula 1), for the treatment and prevention of herpes simplex type 1 virus by inhibiting the replication of HSV 1 virus.